These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18089792)

  • 1. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
    Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
    Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells.
    Lee HY
    Biochem Pharmacol; 2004 Sep; 68(6):1119-24. PubMed ID: 15313408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells.
    Chun KH; Kosmeder JW; Sun S; Pezzuto JM; Lotan R; Hong WK; Lee HY
    J Natl Cancer Inst; 2003 Feb; 95(4):291-302. PubMed ID: 12591985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR.
    Cai Y; Wang Q; Ling Z; Pipeleers D; McDermott P; Pende M; Heimberg H; Van de Casteele M
    Biochem Pharmacol; 2008 May; 75(10):1981-93. PubMed ID: 18377870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells.
    Chen W; Wang X; Zhuang J; Zhang L; Lin Y
    Carcinogenesis; 2007 Oct; 28(10):2114-21. PubMed ID: 17548900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose.
    Jiang W; Zhu Z; Thompson HJ
    Mol Carcinog; 2008 Aug; 47(8):616-28. PubMed ID: 18247380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer.
    Krysan K; Dalwadi H; Sharma S; Põld M; Dubinett S
    Cancer Res; 2004 Sep; 64(18):6359-62. PubMed ID: 15374938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.
    Carretero J; Medina PP; Blanco R; Smit L; Tang M; Roncador G; Maestre L; Conde E; Lopez-Rios F; Clevers HC; Sanchez-Cespedes M
    Oncogene; 2007 Mar; 26(11):1616-25. PubMed ID: 16953221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells.
    Lee HY; Suh YA; Kosmeder JW; Pezzuto JM; Hong WK; Kurie JM
    Clin Cancer Res; 2004 Feb; 10(3):1074-9. PubMed ID: 14871987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
    Xu Y; Chen SY; Ross KN; Balk SP
    Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Shogaol, an active constituent of dietary ginger, induces autophagy by inhibiting the AKT/mTOR pathway in human non-small cell lung cancer A549 cells.
    Hung JY; Hsu YL; Li CT; Ko YC; Ni WC; Huang MS; Kuo PL
    J Agric Food Chem; 2009 Oct; 57(20):9809-16. PubMed ID: 19799425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions.
    Balsara BR; Pei J; Mitsuuchi Y; Page R; Klein-Szanto A; Wang H; Unger M; Testa JR
    Carcinogenesis; 2004 Nov; 25(11):2053-9. PubMed ID: 15240509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of endothelial cell cycle by laminar versus oscillatory flow: distinct modes of interactions of AMP-activated protein kinase and Akt pathways.
    Guo D; Chien S; Shyy JY
    Circ Res; 2007 Mar; 100(4):564-71. PubMed ID: 17272808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
    Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-kappaB pathway.
    Dell'Eva R; Ambrosini C; Minghelli S; Noonan DM; Albini A; Ferrari N
    Carcinogenesis; 2007 Feb; 28(2):404-13. PubMed ID: 16952909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
    Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin gene expression in early-stage non-small cell lung cancer.
    Falleni M; Pellegrini C; Marchetti A; Oprandi B; Buttitta F; Barassi F; Santambrogio L; Coggi G; Bosari S
    J Pathol; 2003 Aug; 200(5):620-6. PubMed ID: 12898598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.
    Zheng Y; Ritzenthaler JD; Sun X; Roman J; Han S
    Cancer Res; 2009 Feb; 69(3):896-904. PubMed ID: 19176380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of mTOR via Akt-dependent and -independent mechanisms in selenium-treated colon cancer cells: involvement of AMPKalpha1.
    Lee YK; Park SY; Kim YM; Kim DC; Lee WS; Surh YJ; Park OJ
    Carcinogenesis; 2010 Jun; 31(6):1092-9. PubMed ID: 20164123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.